Draw cards until you have 6 cards in your hand.
This attack's damage isn't affected by any effects on your opponent's Active Pokémon.
Take another turn after this one. (Skip the between-turns step.) (You can't use more than 1 GX attack in a game.)
Ultra Prism was released in 2018. Series classification for this set is Sun & Moon.
With 178 listed cards, this is a large set by modern TCG standards. As of 2026, the set is 8 years old and now falls into an established back-catalog period.
Dialga-GX (#164) is one of the Rare Rainbow prints in this expansion.
Dialga-GX is a Ultra Prism card from the 2018 release window. Its card type is Pokémon.
The rarity label is Rare Rainbow. Printed HP is 180.
Energy typing is Dragon. It carries a Basic and GX subtype designation.
The card text reads: Pokémon-GX rule: When your Pokémon-GX is Knocked Out, your opponent takes 2 Prize cards. Attack line includes "Overclock", "Shred", and "Timeless-GX".
Dialga-GX from Ultra Prism is currently trading around $39.11. The 7-day delta remains near neutral at 0.0%.
Current pricing is broadly aligned with its 30-day average ($38.35). Its 90-day trading band runs between $37.92 and $41.43, producing a 9% range and low-volatility behavior.
The listed rarity for this print is Rare Rainbow.
Dialga-GX sits within a broader pool of Dialga-GX variants that can be compared by set, rarity, and price. This comparison sample includes 5 alternatives across 2 sets.
In this sample, pricing ranges between $6.56 and $79.19 (1107% total span). Relative to the alternative average ($29.13), this card is +34%.
Notable alternatives include Dialga-GX #138 (Forbidden Light) at $79.19, Dialga-GX #82 (Forbidden Light) at $6.56, Dialga-GX #125 (Forbidden Light) at $34.07, and Dialga-GX #146 (Ultra Prism) at $19.00.
Collector-focused market read: Over the last 7 days, prices have remained stable at 0.0%, indicating a consolidation phase over sudden breakouts. Observed 90-day bounds of $37.92 and $41.43 create a 9% band, matching a low-volatility profile.
Current value remains close to its 30-day mean ($38.35). Graded context points to a substantial premium curve, with PSA 10 at +690% above raw pricing.
PSA 9 is currently around $50.64, while PSA 10 is $309.04.
